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Background: Physical exercise has been linked to beneficial effects on brain plasticity. 
One potential key mechanism for this relationship is an exercise-induced increase of 
brain-derived neurotrophic factor (BDNF). However, the kinetics of BDNF in athletes during 
training phase, extreme exercise competition, and recovery period have not been 
investigated so far.
Methods: We assessed serum BDNF concentrations in 51 marathon runners (23% 
female, mean age 43 years) in a longitudinal study design over a period of 6 months. 
Assessments were conducted during the training period before the marathon and after 
the marathon race during short-term (24 to 72 h) and long-term (3 months) follow-ups. 
Potential confounders (fitness level, sex, and platelet count) were included in subsequent 
linear-model analyses.
Results: Linear mixed-model analyses revealed a main effect of time for BDNF 
concentrations over the study period (F(4,89.389) = 4.296, p = 0.003). Values decreased 
significantly with the lowest values at 72 h after the marathon compared to baseline 
(p = 0.025), a finding that was more pronounced in the larger male cohort.
Conclusion: Prolonged exercise induces a significant decrease in serum BDNF 
concentration 72 h post-exercise. We assume that this observation is mainly driven by 
regenerative mechanisms and a higher muscular utilization.
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INTRODUCTION
Numerous animal and human studies have demonstrated positive 
effects of exercise on various dimensions of brain plasticity (Roig 
et  al., 2013; Northey et  al., 2018; Stern et  al., 2019). Different 
possible mechanisms seem to contribute to this finding, ranging 
from vascular adaptations and metabolic effects to changes in 
levels of neurotrophins and cytokines (Voss et  al., 2013; Suzuki, 
2019). Brain-derived neurotrophic factor (BDNF) is involved in 
neural plasticity mechanisms such as in an increased neuronal 
growth, improved synaptogenesis, and neuronal survival (Tolwani 
et  al., 2002). The exercise-dependent release of BDNF has been 
discussed to be  one of the key mechanisms linking the exercise 
effects and improved cognition in rodents and humans (Hamilton 
and Rhodes, 2015; Szuhany et  al., 2015). Even though primarily 
central BDNF concentrations are assumed to influence cognitive 
performance, peripheral plasma and serum concentrations have 
also shown a positive correlation to central concentrations in 
rodents (Angelucci et  al., 2011). In addition, human studies have 
indicated a close relationship between peripheral BDNF plasma 
and serum concentrations and central effects (e.g., reduced plasma 
and serum concentrations in patients with depressive disorders 
and bipolar disorders that returned to baseline after treatment; 
Polyakova et  al., 2015). Moreover, BDNF does cross the blood–
brain barrier (Pan et al., 1998), supporting the notion that peripheral 
BDNF concentrations can be considered as a proxy of central levels.
A meta-analysis (Dinoff et al., 2017) of 55 studies (eight studies 
with resistance training exercise and the other studies with aerobic 
training exercise, mean exercise duration of 38.9  ±  37.5 
(7–240)  min, 75.4% male; mean age of 27.9  ±  10.8 y; 
mean body mass index (BMI) of 24.0  ±  1.7  kg/m2) revealed an 
approximate 60% increase in BDNF concentrations after a single 
bout of acute exercise in both resistance and aerobic study designs. 
Higher effect sizes were seen during longer durations of exercise, 
for higher cardiorespiratory fitness (VO2max) and for male 
participants. The increase in the studies seemed to be  transient, 
with decreased values back to baseline levels after 15–60  min 
post-exercise. So far, investigations of BDNF kinetics during longer 
follow-up phases after acute exercise are lacking.
Effects of exercise training programs (repeated bouts of 
exercise) on BDNF concentrations have widely been investigated. 
One recent meta-analysis (Marinus et  al., 2019) with older 
participants (>60  years, 17 included studies, either aerobic or 
strength exercise or a combination of both) analyzed exercise 
programs of 8 to 24  weeks (16 studies) and single bouts of 
exercise (one study). Baseline values of BDNF were comparable 
between exercise and control groups. After both single aerobic 
or strength exercise as well as after strength or combined 
aerobic/strength exercise programs, BDNF concentrations 
increased significantly. Training periods for a marathon event 
were not explicitly studied in prior research, but might have 
similar effects as exercise training programs with both designs 
displaying repeated bouts of exercise.
As displayed in these two meta-analyses, many studies 
investigated acute effects of exercise on BDNF concentrations 
and the effects of exercise programs, but the subsequent exercise 
durations were moderate. Longer durations of exercise or 
excessive exercise have rarely been discussed. In one prior 
study (Rasmussen et  al., 2009) with a similar exercise duration 
compared to marathon running, BDNF concentrations increased 
two- to threefold during 4  h of rowing (8 participants, last 
measurement 1  h after cessation of the exercise). In active 
elderly marathon runners and bicyclists (N  =  56 athletes and 
58 sedentary controls), BDNF concentrations were similar to 
the sedentary controls (not measured immediately after a 
marathon; Winker et  al., 2010).
Although the majority of studies discussed BDNF as one 
possible key mechanism in explaining the positive effects of 
different forms of exercise on brain plasticity and cognition, many 
questions remain to be  elucidated. Namely, no study to date has 
examined the kinetics of BDNF during a short- and long-term 
follow-up period after prolonged exercise. It is unclear whether 
the transient increases of BDNF after acute exercise remain stable 
during the follow-up period. If we accept the relationship between 
increased levels of BDNF and improved brain plasticity with 
beneficial effects on cognition and functioning, it is crucial to 
understand the overall BDNF kinetics after acute exercise. This 
especially applies to the kinetics after excessive and prolonged 
exercise. Therefore, the aim of this study was to investigate BDNF 
levels in marathon runners, both in the training period, after 
the marathon and sequentially during the recovery period.
MATERIALS AND METHODS
Our study cohort was part of the Running effects on Cognition 
and Plasticity (ReCaP) trial. The detailed study protocol was 
previously published (Roeh et  al., 2020). In brief, the ReCaP 
trial was a longitudinal study with participants of the Munich 
Marathon in 2017. Inclusion criteria were age between 18 and 
60  years. All participants had to have completed at least one 
half-marathon in the past, possess sufficient German language 
skills, and be able to provide written informed consent. Exclusion 
criteria were relevant neurological, cardiac, or psychiatric diseases, 
pregnancy, and cannabis abuse.
The study timeline is presented in Figure  1 and displays 
the six measurements over 6 months. Participants were assessed 
12 weeks before (Visit -1), 1 week before the marathon (Visit 0), 
and shortly after successful completion of the marathon on 
8th of October 2017 (Visit 1). At Visit 1, all measurements 
were performed within 2  h of the individual completing the 
marathon. The short-term follow-up contained measurements 
at 24 (Visit 2.1) and 72 (Visit 2.2) hours after completing the 
marathon, and the long-term follow-up was set at 12  weeks 
after the marathon (Visit 3).
Participants were asked to refrain from long-distance runs 
in the 3  days prior to the visits to increase the significance of 
the marathon event. The core hours for the visits were between 
9:00  a.m. and 3:00  p.m., which also accounted for the visit 
immediately after the marathon event. All study participants 
underwent a standardized physical examination. BMI was 
calculated as kg/m2. Blood pressure (mmHg) was measured after 
resting in supine position for 5 min and before blood sampling. 
Blood samples were taken from the antecubital vein.
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Total body fat percentage was measured by the skinfold 
caliper technique of Brozek (Brozek et al., 1963) at seven measure 
points and calculated with the formula of Brozek and Jackson 
(Jackson et  al., 1980). Daily activity level of participants as an 
assumption for fitness levels was evaluated with the International 
Physical Activity Questionnaire (IPAQ; Craig et  al., 2003).
All measures were obtained in the premises of the Department 
of Prevention and Sports Medicine of the Technical University 
Munich, except for the visit immediately after the marathon.
Ethics and Registration
The study was performed in accordance with the guiding 
principles of the Declaration of Helsinki 2008, local laws, and 
regulations. The study protocol had been approved by the ethics 
committees of both the Ludwig-Maximilians University Munich 
(approval number 17-148) and the Technical University Munich 
(approval number 218/17 S). The study was registered at https://
www.drks.de/ (DRKS-ID: DRKS00012496). All participants 
provided written informed consent before inclusion in the study.
Human Free BDNF Immunoassay
We measured serum and not plasma BDNF concentrations as 
serum measurements have been used more frequently than 
plasma measurements in previous studies, which improves 
comparability of our results (serum concentrations combine 
blood-borne bound and unbound BDNF, and plasma 
concentrations display only the unbound proportion; Dinoff 
et  al., 2017). BDNF was measured in participants with at least 
four of six successful visits in serum by the human free BDNF 
ELISA kit (R&D Systems, Minneapolis, MN, United  States) 
according to the instructions of the manufacturer with a dilution 
factor of 1:3 (standard and sample). All standards, samples, 
and controls were run once. A sigmoid curve was fitted on 
the resulting data, and the sample concentrations were calculated 
by the Dynex DS2 software.
Platelet counts were measured with Sysmex fluorescence 
flow cytometry (XE-2100D, Sysmex Xtra 2/2008) according to 
the instructions of the manufacturer and in line with the ICSH 
reference methods (International Council for Standardization 
in Hematology).
In a second step, results of serum BDNF concentrations 
and platelet count were corrected according to the method 
of Dill and Costill for dehydration (Dill and Costill, 1974; 
Alis et  al., 2015).
Statistical Analysis
Analyses were performed using SPSS 25 (IBM, Armonk, NY, 
United  States) with a significance level of α  =  0.05. Changes 
of BDNF concentrations and platelet counts for the within-
subject factor “time” were evaluated by general linear mixed-
models (LMM) with a diagonal covariance matrix in subjects 
with complete BDNF data for all visits. In case of a significant 
main effect of “time,” post hoc contrasts were calculated by 
testing a given measurement against baseline and adjusted for 
multiple comparisons (Sidak correction). We further conducted 
a sensitivity analysis by applying LMM for the time visits V0, 
V2.1, and V2.2 to display the short-term changes of BDNF 
between 24 and 72 h after the marathon. Moreover, we wanted 
to exclude the time point visit 1 (within 2 h after the marathon), 
as we might have missed the acute changes after the marathon 
(As displayed, they peak at around 30  min after cessation 
of exercise.)
For evaluating possible moderators of BDNF (dependent 
variable) over the course of the study period, we  thereafter 
included sex (between-subject factor) and physical activity levels 
(IPAQ scores, covariate) in a linear model analyses (repeated 
measures ANOVA) and adjusted for multiple comparisons 
(Sidak correction). Finally, for evaluating the influence of platelet 
count on BDNF concentration, we  applied Pearson correlation 
for each visit and adjusted for multiple testing [Bonferroni 
correction with α  =  0.008 for six visits (0.05/6)].
Figure  2 was produced with R version 4.0.2 (R Foundation 
for Statistical Computing, Vienna, Austria).
RESULTS
Of the initially included 100 participants, 71 successfully 
completed the marathon and 59 participants were examined 
at visit 3 (last measurement at the end of the six-month study 
period). Complete data sets of six visits with BDNF levels 
were obtained in 51 participants [male/female = 42:9, mean 
age 42.7  ±  10.2 y, mean BMI  =  23.4  ±  2.5  kg/m2, mean blood 
pressure systolic/diastolic at baseline (V-1)  = 122.8/80.7 ± 
11.3/6.4  mmHg, mean IPAQ at baseline (V-1)  = 6299.8  ± 
6040.7, mean training kilometers/week at V-1  = 42.3  ±  21.6, 
mean number of prior marathon events  =  2.1  ±  5.1, mean 
marathon finishing time female/male  =  264.7 ± 
48.0/231.1  ±  31.4  min, and mean IPAQ at last visit 
(V3)  =  5038.7  ±  5857.5]. At visit 2.2, results for blood count 
FIGURE 1 | Study time: Longitudinal measurement of serum brain-derived neurotrophic factor (BDNF) concentrations around Munich Marathon 2017. Hrs, hours.
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were missing in one participant due to a technical error, so 
at that time point, N for platelet count (and corrections for 
plasma volume shift) was 50.
Body fat percentage was 15.4 ± 4.8% in male and 22.2 ± 5.4% 
in female participants. Descriptive statistics and the complete 
test statistics are presented in Table  1 Corrected values for 
BDNF and platelet count (Dill and Costill method) are presented 
in Supplementary Table  1, and the results were not 
significantly changed.
Linear mixed-model revealed a significant effect of time 
(F(4,98.389)  =  4.206, p  =  0.003), indicating BDNF concentration 
changes over the study period. In the short-term follow-up, 
the values decreased to levels below baseline with the lowest 
value at visit 2.2 (72  h after the marathon, p  =  0.025). At the 
last visit 3  months after the marathon event, there was no 
significant difference compared to baseline. Maximal values 
were reached at visit 1 (not significant compared to baseline), 
shortly after the marathon. Figure  2 shows a visualization of 
BDNF (total) values over the whole study period. In a sensitivity 
analysis for short-term follow-up without the visits V-1, V1, 
and V3, the results of the minimal values 72  h after the 
marathon were confirmed (p  =  0.003). Also, visit 2.1 at 24  h 
after the marathon showed a significant decrease compared to 
visit 0 (p  =  0.036). See Table  2 for detailed results including 
platelet count (no significant changes over these visits).
Exploratory Analysis of Influencing Factors
The LMM for the platelet count showed a significant effect 
of time: (F(5,87.319)  =  5.234, p  <  0.001). Platelet count reached 
its maximum at visit 3 shortly after the marathon (p  <  0.001; 
see Table  1). We  calculated Pearson correlations of serum 
BDNF concentration and platelet count (N  =  51) for each 
visit to further examine a significant interaction. With the 
adjusted significance level after Bonferroni correction for multiple 
testing (α  =  0.008), no correlation reached significance (V-1: 
r  =  0.212, p  =  0.135; V0: r  =  0.240, p  =  0.089; V1: r  =  0.304, 
p = 0.030; V2.1: r = 0.094, p = 0.511; V2.2: r = 0.321, p = 0.023; 
V3: r  =  0.380, p  =  0.006). This points to different and not 
directly related kinetics of both factors.
As displayed, prior research has indicated higher effect sizes 
of BDNF increases after acute exercise in male participants 
and in participants with higher fitness levels. In the repeated 
measures ANOVA with dependent variable BDNF, the between-
subject factor sex, and the covariate IPAQ score, analyses 
confirmed a significant effect of time with F(5,235)  =  4.704, 
p  <  0.001. The interactions of BDNF × IPAQ (F(5,235)  =  1.437, 
p  =  0.212), and of BDNF × sex (F(5,235)  =  1.142, p  =  0.339) 
were not significant.
DISCUSSION
For the first time, we  evaluated the kinetics of BDNF levels 
in healthy marathon runners in a longitudinal design over 
6  months. The study period included the intensive training 
period prior to the marathon (3  months, visit -1), a visit in 
the tapering phase around 1  week before the marathon event 
(visit 0), measurements within 2  h after crossing the finishing 
line (visit 1), and short-term (24  h, visit 2.1 and 72  h, visit 
2.2) as well as long-term (3 months, visit 3) follow-up periods. 
BDNF concentrations decreased significantly below baseline 
levels at visit 2.2 (72  h post-competition).
Acute Effects Immediately After Cessation 
of Exercise
Prior literature has primarily focused on acute effects of exercise 
on BDNF levels. Evidence accumulated that BDNF significantly 
increases after acute exercise and that higher cardiorespiratory 
fitness could moderate this effect with higher increases in the 
group of higher cardiorespiratory fitness (Dinoff et  al., 2017). 
The release of peripheral BDNF after acute exercise is mediated 
by various possible mechanisms. BDNF can be  released by 
platelets (Fujimura et  al., 2002), peripheral blood mononuclear 
cells (Brunelli et al., 2012), skeletal and cardiac muscle (Matthews 
et al., 2009), and endothelial cells (Prigent-Tessier et  al., 2013). 
After cessation of exercise, peripheral BDNF concentrations 
rapidly (serum levels faster than plasma levels) return to baseline 
values (within 30–60 min; Yarrow et al., 2010; Gilder et al., 2014).
Due to our time frame for blood examinations within 2  h 
after crossing the finishing line, we  might have missed the 
early peak of BDNF levels. Therefore, our results cannot directly 
be  compared to prior findings. Even though we  observed a 
BDNF increase after the marathon, this was not significant 
(trend level).
Decrease of BDNF in the Follow-Up Period
For the first time, we evaluated serum BDNF kinetics including 
a short-term follow-up period of 24 to 72  h after marathon 
running and we  could demonstrate a significant decline of 
BDNF both in the analysis including all visits and in the 
sensitivity analysis with the visits 0, 2.1 and 2.2.
FIGURE 2 | Serum BDNF concentrations over the study period. Mths, 
months. Red color and *, significant difference compared to baseline visit in 
Linear mixed-model (LMM) analysis (details in Table 1).
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As prior studies did not apply such study design, our findings 
of decreased BDNF levels after 72 h cannot directly be compared 
to the existing literature. Nevertheless, two other studies revealed 
decreased levels within 1  h post-exercise: in one interventional 
study (N = 8 sedentary participants and N = 8 active participants) 
with three different intensities of exercise tests, a decrease of 
BDNF after maximal intensity exercise was observed only in 
the physically active group [30–60  min post-exercise (Nofuji 
et  al., 2012)]. In another small interventional study (N  =  26 
trained cyclists), decreased levels of BDNF were detected 10 min 
after the first set and 60  min after the third set of sprint 
interval training in the experimental group after two and 
6  months (Hebisz et  al., 2019). Authors of both studies 
hypothesized regenerative functions of BDNF to contribute to 
the finding of decreased BDNF levels in terms of increased 
utilization of BDNF for muscle regeneration. This idea was 
based on the observation that BDNF knock-out mice showed 
delayed muscle regeneration (Clow and Jasmin, 2010). We  can 
extrapolate this finding on our results, as muscle regeneration 
after prolonged exercise will require more time and therefore 
a higher (total) utilization of BDNF. Another possible mechanism 
to explain the unexpected effect of decreased BDNF levels could 
be an enhanced utilization by an upregulation of TrkB (tyrosine 
protein kinase) receptor in the peripheral tissues in the context 
of exercise (Gómez-Pinilla et  al., 2002; Nofuji et  al., 2012).
These mechanisms provide potential explanations of our 
findings of decreased levels of BDNF 3  days after a marathon, 
but comparability is reduced because of the different time points 
of BDNF assessments across our and the reference studies. 
However, a marathon with a mean duration of three to 5  h 
of mainly aerobic exercise needs longer regeneration periods 
and therefore the decreased BDNF levels could still be explained 
in this context. Future studies may add more follow-up assessments 
in order to thoroughly evaluate the BDNF kinetics between 
72  h and 3  months after prolonged exercise. Such approaches 
will help to detect the first time point of normalized BDNF 
concentrations after such strenuous interventions.
Exploratory Analysis of Influencing Factors
As recommended (Walsh and Tschakovsky, 2018), 
we  simultaneously evaluated platelet counts in our cohort (see 
Tables 1 and 2). This approach is based on the observation 
that BDNF is stored in large proportions in platelets and that 
this platelet-bound proportion was discussed to contribute to 
the exercise-associated increase in serum concentrations (Fujimura 
et  al., 2002). The pattern of the two parameters was different, 
and platelet count reached its maximum immediately after the 
marathon but did not similarly decrease in the follow-up period. 
Correlations for each visit were not statistically significant after 
correction for multiple testing. This pattern indicates that the 
platelet count does not offer an explanation for the BDNF kinetics 
in our study pointing towards independent dynamics.
Furthermore, we  included sex and an estimation of fitness 
levels (measured with IPAQ) to covary our analyses. None of 
the two moderator variables had a significant impact on BDNF 
levels over the study period. However, the reader should be aware 
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male cohort (9 vs. 42), reducing statistic validity. Prior investigations 
displayed higher effect sizes of increased BDNF concentrations 
in male participants after acute exercise (Dinoff et  al., 2017). 
In our cohort, the female participants had overall higher levels 
of BDNF, but the changes throughout the study period did not 
reach significance. Even though these results have to be interpreted 
cautiously because of the small sample size in the female cohort, 
a possible explanation for the difference of BDNF kinetics 
throughout the study period could be  the result of differences 
in body composition (higher body fat percentage with 22.2 ± 5.4% 
vs. 15.4  ±  4.8% and lower muscle mass in female participants). 
If we accept the described hypothesis of higher muscular utilization 
of BDNF during regeneration, male participants with higher 
muscle mass would consecutively require higher amounts of 
BDNF. Our study cohort represents common marathon participants 
with largely male runners (in our cohort 23% female runners). 
Future studies should further investigate this difference with a 
more balanced cohort of male/female participants.
The association of regular exercise and BDNF concentrations 
shows highly variable results (Walsh and Tschakovsky, 2018) 
with more studies pointing to a more pronounced increase 
of BDNF in participants with higher cardiorespiratory fitness 
(Dinoff et  al., 2017). We  did not find an association between 
BDNF kinetics and IPAQ scores in our cohort. One possible 
explanation could be  the homogenous fitness levels of our 
participants, as they were all well-trained and had experience 
in endurance competitions (see inclusion criteria).
Limitations
We were able to display changes in serum BDNF concentrations 
in a large cohort of healthy marathon runners. However, we were 
not able not compare the BDNF results to a control group 
with no physical exercise over the study period of 6  months. 
Furthermore, our study cohort was homogenous in terms of 
fitness levels and heterogeneous in terms of sex (with larger 
sample sizes for male participants). Thus, we might have missed 
influences of fitness levels and sex on BDNF levels after the 
marathon. Even though interpretation of sex differences is 
limited because of the different sample sizes, we  aimed to 
address this point with regard to prior findings in terms of 
an explanatory approach. Future studies should investigate a 
more heterogeneous cohort and include more female participants 
to help generalize the results.
As displayed, we  measured BDNF levels within 2  h post-
exercise and might have missed the maximal increase immediately 
post-exercise (which was found to peak 30–60 min post-exercise 
in prior studies). To account for this, we  further applied a 
sensitivity analysis for the short-term follow-up period excluding 
visit 1. BDNF evaluations in an experimental design (e.g., 
immediate measurement of BDNF concentrations after a marathon 
on a treadmill) would help validate our results.
Even though we  have provided new insights into 
the kinetics of BDNF after acute exercise, we  can only 
hypothesize about the possible causal mechanisms at this 
stage. We could not exclude the possibility that very strenuous 
exercise can even have negative effects on the central nervous 
system (with a subsequent reduction in BDNF levels).
CONCLUSION
We measured the kinetics of BDNF during a training period, 
in response to a marathon event and during follow-up in 
in a longitudinal naturalistic six-month study. We  were able 
to show a significant decrease of BDNF concentrations in 
the marathon recovery period. One possible mechanism to 
explain this observation might be  related to a higher BDNF 
utilization for muscular regeneration. Prior studies primarily 
examined the acute kinetics within the first hours after 
cessation of exercise, so this decline could not be  displayed. 
Thus, based on our findings, future studies should focus 
on kinetics of BDNF and underlying mechanisms over a 
longer period of time rather than focusing on single 
post-exercise measures.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will 
be  made available by the authors, without undue reservation.
ETHICS STATEMENT
The studies involving human participants were reviewed and 
approved by the Ethics Committees of both the Ludwig-Maximilians 
TABLE 2 | Sensitivity analysis: serum BDNF concentration and platelet count over the visits V0 to V2.2 (before the marathon and the short-term follow-up), excluding 
visits V-1 and V3; mean and SD.

























Effect of time and LMM analysis of each visit after the marathon vs. V0. Main effect of time (LMM) with F, df, p. In case of significant effect of time in the LMM, post hoc comparisons 
with Sidak correction are presented for each visit vs. V0.
Roeh et al. BDNF Kinetics and Prolonged Exercise
Frontiers in Physiology | www.frontiersin.org 7 July 2021 | Volume 12 | Article 668454
University Munich (approval number 17-148) and the Technical 
University Munich (approval number 218/17 S). The patients/
participants provided their written informed consent to participate 
in this study.
AUTHOR CONTRIBUTIONS
AR, JoS, AH, and JuS designed the study. AR, JuS, JH, and 
SH collected data. AR, JoS, AH, MH, and PF interpreted and 
analyzed data. AR wrote the first draft of the manuscript. 
All authors revised the manuscript critically and provided 
consent of the final version.
SUPPLEMENTARY MATERIAL





Alis, R., Sanchis-Gomar, F., Primo-Carrau, C., Lozano-Calve, S., Dipalo, M., 
Aloe, R., et al. (2015). Hemoconcentration induced by exercise: revisiting 
the dill and costill equation. Scand. J. Med. Sci. Sports 25, e630–e637. doi: 
10.1111/sms.12393
Angelucci, F., Gelfo, F., De, B. P., Caltagirone, C., and Petrosini, L. (2011). 
BDNF concentrations are decreased in serum and parietal cortex in 
immunotoxin 192 IgG-Saporin rat model of cholinergic degeneration. 
Neurochem. Int. 59, 1–4. doi: 10.1016/j.neuint.2011.04.010
Brozek, J., Grande, F., Anderson, J. T., and Keys, A. (1963). Densitometric 
analysis of body composition: revision of some quantitative assumptions. 
Ann. N. Y. Acad. Sci. 110, 113–140. doi: 10.1111/j.1749-6632.1963. 
tb17079.x
Brunelli, A., Dimauro, I., Sgrò, P., Emerenziani, G. P., Magi, F., Baldari, C., 
et al. (2012). Acute exercise modulates BDNF and pro-BDNF protein content 
in immune cells. Med. Sci. Sports Exerc. 44, 1871–1880. doi: 10.1249/
MSS.0b013e31825ab69b
Clow, C., and Jasmin, B. J. (2010). Brain-derived neurotrophic factor regulates 
satellite cell differentiation and skeltal muscle regeneration. Mol. Biol. Cell 
21, 2182–2190. doi: 10.1091/mbc.e10-02-0154
Craig, C. L., Marshall, A. L., Sjöström, M., Bauman, A. E., Booth, M. L., 
Ainsworth, B. E., et al. (2003). International physical activity questionnaire: 
12-country reliability and validity. Med. Sci. Sports Exerc. 35, 1381–1395. 
doi: 10.1249/01.MSS.0000078924.61453.FB
Dill, D. B., and Costill, D. L. (1974). Calculation of percentage changes in 
volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 
37, 247–248. doi: 10.1152/jappl.1974.37.2.247
Dinoff, A., Herrmann, N., Swardfager, W., and Lanctôt, K. L. (2017). The effect 
of acute exercise on blood concentrations of brain-derived neurotrophic 
factor in healthy adults: a meta-analysis. Eur. J. Neurosci. 46, 1635–1646. 
doi: 10.1111/ejn.13603
Fujimura, H., Altar, C. A., Chen, R., Nakamura, T., Nakahashi, T., Kambayashi, J., 
et al. (2002). Brain-derived neurotrophic factor is stored in human platelets 
and released by agonist stimulation. Thromb. Haemost. 87, 728–734. doi: 
10.1055/s-0037-1613072
Gilder, M., Ramsbottom, R., Currie, J., Sheridan, B., and Nevill, A. M. (2014). 
Effect of fat free mass on serum and plasma BDNF concentrations during 
exercise and recovery in healthy young men. Neurosci. Lett. 560, 137–141. 
doi: 10.1016/j.neulet.2013.12.034
Gómez-Pinilla, F., Ying, Z., Roy, R. R., Molteni, R., and Edgerton, V. R. (2002). 
Voluntary exercise induces a BDNF-mediated mechanism that promotes 
neuroplasticity. J. Neurophysiol. 88, 2187–2195. doi: 10.1152/jn.00152.2002
Hamilton, G. F., and Rhodes, J. S. (2015). Exercise regulation of cognitive 
function and neuroplasticity in the healthy and diseased brain. Prog. Mol. 
Biol. Transl. Sci. 135, 381–406. doi: 10.1016/bs.pmbts.2015.07.004
Hebisz, P., Hebisz, R., Murawska-Ciałowicz, E., and Zatoń, M. (2019). Changes 
in exercise capacity and serum BDNF following long-term sprint interval 
training in well-trained cyclists. Appl. Physiol. Nutr. Metab. 44, 499–506. 
doi: 10.1139/apnm-2018-0427
Jackson, A. S., Pollock, M. L., and Ward, A. (1980). Generalized equations for 
predicting body density of women. Med. Sci. Sports Exerc. 12, 175–181.
Marinus, N., Hansen, D., Feys, P., Meesen, R., Timmermans, A., and Spildooren, J. 
(2019). The impact of different types of exercise training on peripheral 
blood brain-derived neurotrophic factor concentrations in older adults: a 
meta-analysis. Sports Med. 49, 1529–1546. doi: 10.1007/s40279-019-01148-z
Matthews, V. B., Aström, M.-B., Chan, M. H. S., Bruce, C. R., Krabbe, K. S., 
Prelovsek, O., et al. (2009). Brain-derived neurotrophic factor is produced 
by skeletal muscle cells in response to contraction and enhances fat oxidation 
via activation of AMP-activated protein kinase. Diabetologia 52, 1409–1418. 
doi: 10.1007/s00125-009-1364-1
Nofuji, Y., Suwa, M., Sasaki, H., Ichimiya, A., Nishichi, R., and Kumagai, S. 
(2012). Different circulating brain-derived neurotrophic factor responses to 
acute exercise between physically active and sedentary subjects. J. Sports 
Sci. Med. 11, 83–88.
Northey, J. M., Cherbuin, N., Pumpa, K. L., Smee, D. J., and Rattray, B. (2018). 
Exercise interventions for cognitive function in adults older than 50: a 
systematic review with meta-analysis. Br. J. Sports Med. 52, 154–160. doi: 
10.1136/bjsports-2016-096587
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., and Kastin, A. J. (1998). 
Transport of brain-derived neurotrophic factor across the blood–brain barrier. 
Neuropharmacology 37, 1553–1561. doi: 10.1016/S0028-3908(98)00141-5
Polyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., and 
Schroeter, M. L. (2015). BDNF as a biomarker for successful treatment of 
mood disorders: a systematic & quantitative meta-analysis. J. Affect. Disord. 
174, 432–440. doi: 10.1016/j.jad.2014.11.044
Prigent-Tessier, A., Quirié, A., Maguin-Gaté, K., Szostak, J., Mossiat, C., 
Nappey, M., et al. (2013). Physical training and hypertension have opposite 
effects on endothelial brain-derived neurotrophic factor expression. Cardiovasc. 
Res. 100, 374–382. doi: 10.1093/cvr/cvt219
Rasmussen, P., Brassard, P., Adser, H., Pedersen, M. V., Leick, L., Hart, E., 
et al. (2009). Evidence for a release of brain-derived neurotrophic factor 
from the brain during exercise. Exp. Physiol. 94, 1062–1069. doi: 10.1113/
expphysiol.2009.048512
Roeh, A., Bunse, T., Lembeck, M., Handrack, M., Pross, B., Schoenfeld, J., 
et al. (2020). Running effects on cognition and plasticity (ReCaP): study 
protocol of a longitudinal examination of multimodal adaptations of marathon 
running. Res. Sports Med. 28, 241–255. doi: 10.1080/15438627. 2019.1647205
Roig, M., Nordbrandt, S., Geertsen, S. S., and Nielsen, J. B. (2013). The 
effects of cardiovascular exercise on human memory: a review with meta-
analysis. Neurosci. Biobehav. Rev. 37, 1645–1666. doi: 10.1016/j.
neubiorev.2013.06.012
Stern, Y., Mac Kay-Brandt, A., Lee, S., McKinley, P., McIntyre, K., Razlighi, Q., 
et al. (2019). Effect of aerobic exercise on cognition in younger adults: a 
randomized clinical trial. Neurology 92, e905–e916. doi: 10.1212/
WNL.0000000000007003
Suzuki, K. (2019). Characterization of exercise-induced cytokine release, the 
impacts on the body, the mechanisms and modulations. Int. J. Sports Exerc. 
Med. 5, 1–13. doi: 10.23937/2469-5718/1510122
Szuhany, K. L., Bugatti, M., and Otto, M. W. (2015). A meta-analytic review 
of the effects of exercise on brain-derived neurotrophic factor. J. Psychiatr. 
Res. 60, 56–64. doi: 10.1016/j.jpsychires.2014.10.003
Tolwani, R. J., Buckmaster, P. S., Varma, S., Cosgaya, J. M., Wu, Y., Suri, C., et al. 
(2002). BDNF overexpression increases dendrite complexity in hippocampal 
dentate gyrus. Neuroscience 114, 795–805. doi: 10.1016/S0306-4522(02)00301-9
Voss, M. W., Vivar, C., Kramer, A. F., and van Praag, H. (2013). Bridging 
animal and human models of exercise-induced brain plasticity. Trends Cogn. 
Sci. 17, 525–544. doi: 10.1016/j.tics.2013.08.001
Roeh et al. BDNF Kinetics and Prolonged Exercise
Frontiers in Physiology | www.frontiersin.org 8 July 2021 | Volume 12 | Article 668454
Walsh, J. J., and Tschakovsky, M. E. (2018). Exercise and circulating BDNF: 
mechanisms of release and implications for the design of exercise interventions. 
Appl. Physiol. Nutr. Metab. 43, 1095–1104. doi: 10.1139/apnm-2018-0192
Winker, R., Lukas, I., Perkmann, T., Haslacher, H., Ponocny, E., Lehrner, J., 
et al. (2010). Cognitive function in elderly marathon runners: cross-sectional 
data from the marathon trial (APSOEM). Wien. Klin. Wochenschr. 122, 
704–716. doi: 10.1007/s00508-010-1485-z
Yarrow, J. F., White, L. J., McCoy, S. C., and Borst, S. E. (2010). Training 
augments resistance exercise induced elevation of circulating brain derived 
neurotrophic factor (BDNF). Neurosci. Lett. 479, 161–165. doi: 10.1016/j.
neulet.2010.05.058
Conflict of Interest: The authors declare that the research was conducted in 
the absence of any commercial or financial relationships that could be  construed 
as a potential conflict of interest.
Copyright © 2021 Roeh, Holdenrieder, Schoenfeld, Haeckert, Halle, Falkai, Scherr 
and Hasan. This is an open-access article distributed under the terms of the Creative 
Commons Attribution License (CC BY). The use, distribution or reproduction in 
other forums is permitted, provided the original author(s) and the copyright owner(s) 
are credited and that the original publication in this journal is cited, in accordance 
with accepted academic practice. No use, distribution or reproduction is permitted 
which does not comply with these terms.
